Safety Profile of HTX-019 Administered as an Intravenous Push in Cancer Patients: A Retrospective Review
Crossref DOI link: https://doi.org/10.1007/s12325-019-0877-3
Published Online: 2019-01-31
Published Print: 2019-03-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Walton, Gary D.
Funding for this research was provided by:
Heron Therapeutics, Inc.
Text and Data Mining valid from 2019-01-31
Version of Record valid from 2019-01-31
Article History
Received: 30 November 2018
First Online: 31 January 2019